We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
323 result(s) found, displaying 171 to 180
-
-
Designation or determinationPriority review
-
Prescription medicine registrationActive ingredients: dapagliflozin propanediol monohydrate.
-
Designation or determinationProvisional approval
-
Cancellation by sponsorRequested by AstraZeneca Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LYNPARZA olaparib 100 mg film coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LYNPARZA olaparib 150 mg film coated tablet blister pack.
-
Section 14, TGO91 consentProduct(s) approved for Supply with noncompliant labelling.
-
Designation or determinationPriority review
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FASENRA benralizumab 30 mg in 1 mL solution for injection prefilled syringe.